<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0"
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main" xml:id="_XFJfV59"></title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author role="corresp">
							<persName><roleName>D.O</roleName><forename type="first">Sarang</forename><forename type="middle">K</forename><surname>Yoon</surname></persName>
							<email>sarang.yoon@hsc.utah.edu</email>
							<affiliation key="aff0">
								<note type="raw_affiliation">University of Utah Health Salt Lake City , UT</note>
								<orgName type="institution">University of Utah Health Salt Lake City</orgName>
								<address>
									<region>UT</region>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>M.D</roleName><forename type="first">Jefferey</forename><forename type="middle">L</forename><surname>Burgess</surname></persName>
							<affiliation key="aff0">
								<note type="raw_affiliation">University of Utah Health Salt Lake City , UT</note>
								<orgName type="institution">University of Utah Health Salt Lake City</orgName>
								<address>
									<region>UT</region>
								</address>
							</affiliation>
						</author>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">F1BC9EBAD29AB2EAC3EE2B90F99B9862</idno>
					<idno type="DOI">10.1056/nejmc2201821</idno>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.8.2" ident="GROBID" when="2025-08-31T07:40+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<label type="revision">a91ee48</label>
					<label type="parameters">startPage=-1, endPage=-1, consolidateCitations=2, consolidateHeader=2, consolidateFunders=1, includeRawAffiliations=true, includeRawCitations=true, includeRawCopyrights=true, generateTeiIds=true, generateTeiCoordinates=[all], sentenceSegmentation=true, flavor=null</label>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_8Zu4Jp9"><p xml:id="_te9ZqnN"><s xml:id="_vvJAHXe">vaccine against medically attended Covid-19 during a period when the delta variant was predominant. <ref type="bibr" target="#b5">4</ref></s><s xml:id="_xwKfFuG">In contrast, our estimate of vaccine effectiveness of 60% for three doses against omicron infection was lower than the corresponding effectiveness of three doses against medically attended Covid-19 (82 to 90%) in the same study.</s><s xml:id="_DXAmps4">Although in our study a third dose improved protection against omicron infection (relative vaccine effectiveness, 60%), relative protection was much higher against delta infection (86%).</s><s xml:id="_U3vzm4q">Lower vaccine effectiveness against mild or asymptomatic omicron infection is consistent with recent data showing lower protection in the ambulatory care setting and among adults who were tested for SARS-CoV-2 during the periods of circulation of the delta and omicron variants. <ref type="bibr" target="#b6">5</ref></s><s xml:id="_S3bwaYj">espite indicating a decline in vaccine effectiveness, these results show continued effectiveness against clinically severe outcomes related to both variants.</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<facsimile>
		<surface n="1" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="2" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
		<surface n="3" ulx="0.0" uly="0.0" lrx="567.0" lry="756.0"/>
	</facsimile>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0" xml:id="_fX3WsYV"><p xml:id="_SqWHshu"><s xml:id="_YEErUSM">To the Editor: Reports of silent hypoxia in patients with coronavirus disease 2019 (Covid-19) have raised the question of whether patients should use pulse oximeters at home to measure oxygen saturation rather than relying on subjective dyspnea as an indicator of clinical deterioration. <ref type="bibr" target="#b2">1,</ref><ref type="bibr" target="#b3">2</ref></s><s xml:id="_RcJEs9j">Many Covid-19 remote-monitoring programs include home pulse oximetry, <ref type="bibr" target="#b4">3,</ref><ref type="bibr" target="#b5">4</ref> but the effectiveness of these programs remains unknown.</s><s xml:id="_GFGuPNA">We report the findings from a randomized trial that assessed a text message-based remote-monitoring program (COVID Watch) supplemented with monitoring of oxygen saturation by means of a home pulse oximeter (Clinical-Trials.gov</s><s xml:id="_6tz3VCE">number, NCT04581863).</s></p><p xml:id="_Zr8dqcr"><s xml:id="_cc23STd">As part of routine care in our six-hospital health system (which includes more than 500 outpatient practices), adults in our electronic health record with Covid-19 infection -as determined by their clinician or a confirmed positive test for Covid-19 -are enrolled in COVID Watch, a 2-week program involving twice-daily automated text messages inquiring about dyspnea and offering rapid callbacks from nurses when appropriate.</s><s xml:id="_VskFbAJ">This program has been associated with improved survival as compared with no remote monitoring. <ref type="bibr" target="#b6">5</ref></s><s xml:id="_HWFaQ8c">rom November 29, 2020, to February 5, 2021, we randomly assigned in a 1:1 ratio patients who were enrolled in COVID Watch to participate in</s></p><p xml:id="_4kfuT6W"><s xml:id="_WmDNQVS">The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_aRhk2Zq">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_4eqx6kf">Copyright © 2022 Massachusetts Medical Society.</s><s xml:id="_rHYk9UE">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s></p><p xml:id="_VeWkkQ9"><s xml:id="_yXRpeNe">the standard monitoring program in addition to home pulse oximetry or the standard program alone.</s><s xml:id="_bMkh7zS">Patients in the pulse oximetry group were provided a pulse oximeter and were monitored for subjective symptoms or a low or declining oxygen saturation.</s><s xml:id="_5TYzMuY">Ethical considerations pre-</s></p><p xml:id="_cKrHfQd"><s xml:id="_Sp6S3P9">Table 1.</s><s xml:id="_qfE77yk">Primary and Key Exploratory Outcomes among Patients with Covid-19 within 30 Days after Enrollment (Intention-to-Treat Population).*</s><s xml:id="_mxe363Y">Outcome Standard Program + Pulse Oximetry (N = 611) Standard Program (N = 606) Difference (95% CI) † P Value Primary outcome Days alive and out of the hospital 29.4±2.8</s><s xml:id="_PbXNmgU">29.5±2.3</s><s xml:id="_RRBAWJ9">-0.1 (-0.4 to 0.2) 0.58 Exploratory outcomes Anxiety level ‡ Day of enrollment 2.8±1.3 2.9±1.3 -0.1 (-0.3 to 0.1) Day 7 2.3±1.3 2.3±1.3 0.0 (-0.2 to 0.3) Day 14 2.0±1.3 2.0±1.2</s><s xml:id="_N36XhUh">0.0 (-0.3 to 0.4) Emergency department encounter -no. of patients (%) 57 (9.3) 68 (11.2) -1.9 (-5.3 to 1.5) § Within health system -no. of patients/total no.</s><s xml:id="_C4UgE2V">(%) 56/57 (98.2) 67/68 (98.5) -0.3 (-23.9 to 23.3) § Days from enrollment to encounter 9.2±6.9</s><s xml:id="_8eDtnvj">8.8±7.3 0.4 (-2.1 to 3.0) Lowest recorded systolic blood pressure -mm Hg ¶ 121.5±15.7 121.3±14.8</s><s xml:id="_hwud45M">0.2 (-5.3 to 5.7) Lowest recorded oxygen saturation -% ¶ 93.7±5.1 94.2±11.8</s><s xml:id="_WbN7Cq7">-0.5 (-3.7 to 2.7) Supplemental oxygen provided -no. of patients/ total no.</s><s xml:id="_2JvRs9m">(%) ¶ 14/56 (25.0) 11/67 (16.4) 8.6 (-6.6 to 23.8) § Maximum temperature -°F ¶ 99.1±1.1 98.7±1.2 0.4 (-0.1 to 0.8) Hospitalization -no. of patients/total no.</s><s xml:id="_aKXpssS">(%) 43/611 (7.0) 41/606 (6.8) 0.2 (-2.6 to 3.2) § Within health system 39/43 (90.7) 41/41 (100.0)</s><s xml:id="_AyG8X2F">-9.3 (-39.9 to 21.3) § Intubation and ventilator support provided ¶ 4/39 (10.3) 1/41 (2.4) 7.8 (-3.1 to 18.8) § Death -no.</s><s xml:id="_XxxYkd5">(%) 5 (0.8) 3 (0.5) 0.3 (-0.7 to 1.5) § Health-system encounter -no.</s><s xml:id="_V6ggFNW">per patient ¶‖ Office visit 0.2±0.6 0.2±0.5 0.0 (-0.1 to 0.1) Telemedicine 0.5±0.9</s><s xml:id="_5pY9ybU">0.5±0.9</s><s xml:id="_ZhrQRx3">0.0 (-0.1 to 0.1) Telephone 3.3±4.2</s><s xml:id="_vFduKt8">2.4±3.3 0.9 (0.4 to 1.3) * Plus-minus values are means ±SD.</s><s xml:id="_y5YSwRg">Patients with test-confirmed coronavirus disease 2019 (Covid-19) who were enrolled in the COVID Watch remote-monitoring program were randomly assigned to receive the standard monitoring program or the program supplemented with home</s></p><p xml:id="_JCqy2QN"><s xml:id="_zGs2rbd">monitoring of oxygen saturation with the use of a pulse oximeter.</s><s xml:id="_zKXMFPw">Unless otherwise noted, data are shown for patients who presented to a hospital within the health system or to any of 53 hospitals outside the health system and whose data were captured in the regional health information exchange.</s><s xml:id="_xTc9Fww">† The confidence intervals have not been adjusted for multiplicity and cannot be used to infer treatment effects for outcomes other than the primary outcome.</s><s xml:id="_2XwbmNS">‡ Anxiety was reported by patients in response to the question "In the past 24 hours, how worried have you been about your COVID symptoms?"</s><s xml:id="_6pAVyxp">and was assessed on a scale of 1 to 5, with 1 indicating "not at all worried" and 5 indicating "very worried."</s><s xml:id="_yGgKqDC">The anxiety survey question was adapted from previously validated instruments and modified for this trial and pilot tested for clarity and understanding (see the Supplementary Appendix at NEJM.org for complete patient-reported outcome data sets and associated references).</s><s xml:id="_fqbrRQt">The survey was administered by means of text messaging on the day of enrollment and on days 7 and 14 after enrollment.</s><s xml:id="_feKZEt8">§ The value is the difference in percentage points.</s><s xml:id="_9WppXRE">¶ Data are excluded for patients who presented to any of 53 hospitals outside the health system.</s><s xml:id="_yzMaPjR">‖ Initial callbacks to patients who triggered an escalation during the trial were recorded as telephone encounters in the electronic health record.</s></p><p xml:id="_dBhzWkM"><s xml:id="_K5FeNFr">Patients were subsequently referred for telemedicine visits if indicated on the basis of initial triage with the use of the clinical management protocols of the program.</s><s xml:id="_at4J3Ph">Telemedicine visits were documented visits between a licensed prescriber (advanced practice practitioner or physician) and patient, typically with the use of videoconference technology.</s><s xml:id="_scZU84Z">Telephone calls and telemedicine visits are mutually exclusive.</s><s xml:id="_8EfDqnM">These measures are inclusive of all encounters within the health system, not solely within the COVID Watch program.</s></p><p xml:id="_D5ZPDtj"><s xml:id="_JvuyuCw">The New England Journal of Medicine is produced by NEJM Group, a division of the Massachusetts Medical Society.</s><s xml:id="_X5bHHtC">cluded assigning patients to no monitoring as a control.</s><s xml:id="_ZTeXFKZ">The prespecified primary outcome was the number of days the patient was alive and out of the hospital at 30 days, assessed in patients with test-confirmed Covid-19.</s><s xml:id="_tsba5CE">Exploratory outcomes included patient-reported anxiety levels, use of health care services, and death at 30 days.</s><s xml:id="_BkuYpPP">Details regarding the patients and the trial methods are provided in the Supplementary Appendix, available with the full text of this letter at NEJM.org; the trial protocol is also available at NEJM.org.</s></p><p xml:id="_Sw8qd6x"><s xml:id="_zauzd4E">A total of 1041 patients (606 of whom had test-confirmed Covid-19) were assigned to the standard program group, and 1056 patients (611 of whom had test-confirmed Covid-19) were assigned to the pulse oximetry group.</s><s xml:id="_pqw2WmC">Among patients in the pulse oximetry group, 77.7% submitted at least one pulse oximetry reading; these patients submitted a mean (±SD) of 9.8±8.5 readings, corresponding to a response rate of 69.4±32.8% to pulse oximetry check-ins.</s></p><p xml:id="_4Fu6yyG"><s xml:id="_QVXTNcx">Among patients with test-confirmed Covid-19, there was no significant between-group difference in the number of days they were alive and out of the hospital at 30 days (mean, 29.4 days in the pulse oximetry group and 29.5 days in the standard program group; P = 0.58; difference, -0.1 days; 95% confidence interval [CI], -0.4 to 0.2) (Table <ref type="table">1</ref>).</s><s xml:id="_kAjPp3G">Prespecified subgroup analyses that were specifically powered to detect a difference in the number of days patients were alive and out of the hospital among Black patients as compared with non-Hispanic White patients showed no significant difference in this outcome.</s><s xml:id="_stQYkmw">The mean number of telephone encounters within the health system (an exploratory outcome) was 3.3±4.2 in the pulse oximetry group and 2.4±3.3 in the standard program group (difference, 0.9; 95% CI, 0.4 to 1.3).</s></p><p xml:id="_TWPp55K"><s xml:id="_PFfBBQM">Among patients with Covid-19, the addition of home pulse oximetry to remote monitoring did not result in a greater number of days alive and out of the hospital than subjective assessments of dyspnea alone.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><figDesc><div><p xml:id="_kBu8VHn"><s xml:id="_Hz6MqGn">Downloaded from nejm.org at University of Iowa--Iowa City on July 28, 2025.</s><s xml:id="_xPh599f">Copyright © 2022 Massachusetts Medical Society.</s><s xml:id="_PveqxrF">All rights reserved, including those for text and data mining, AI training, and similar technologies.</s></p></div></figDesc></figure>
		</body>
		<back>
			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<monogr>
		<title/>
		<author>
			<persName><forename type="first">Kathleen</forename><forename type="middle">C</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Anna</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S H P</forename><surname>Krisda</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chaiyachati</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P H</forename><surname>David</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Asch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Ruiying</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Xiong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>David Do</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Austin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Kilaru</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S H P</forename><surname>Doreen Lam</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Andrew Parambath</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Ari</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Friedman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D D</forename><surname>Ph</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Zachary</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Meisel</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S H P</forename><surname>Christopher</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Snider</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P H</forename><surname>Deena</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Chisholm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P H</forename><surname>Kelly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P H E</forename><surname>Jessica</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Hemmons</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Dina Abdel-Rahman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ph</forename><forename type="middle">D</forename><surname>Jeffrey Ebert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">P H</forename><surname>Medha Ghosh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Reilly</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Christina</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H A</forename><surname>O'malley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">B A</forename><surname>Lauren Hahn</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nancy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N P</forename><surname>Mannion</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Ann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Huffenberger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">N</forename><surname>Susan Mcginley</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">R N P</forename><surname>Mohan Balachandran</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">S</forename><surname>Neda Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H C I A</forename><surname>Judy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ph</forename><forename type="middle">D</forename><surname>Shea</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Ph</forename><forename type="middle">D M</forename><surname>Nandita Mitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><surname>Perelman</surname></persName>
		</author>
		<imprint/>
		<respStmt>
			<orgName>School of Medicine, University of Pennsylvania Philadelphia</orgName>
		</respStmt>
	</monogr>
	<note>PA amorga@pennmedicine</note>
	<note type="raw_reference">Kathleen C. Lee, M.D. Anna U. Morgan, M.D., M.S.H.P. Krisda H. Chaiyachati, M.D., M.P.H. David A. Asch, M.D. Ruiying A. Xiong, M.S. David Do, M.D. Austin S. Kilaru, M.D., M.S.H.P. Doreen Lam, B.A. Andrew Parambath, B.A. Ari B. Friedman, M.D., Ph.D. Zachary F. Meisel, M.D., M.S.H.P. Christopher K. Snider, M.P.H. Deena L. Chisholm, M.P.H. Sheila Kelly, M.P.H. Jessica E. Hemmons, M.S. Dina Abdel-Rahman, B.S. Jeffrey Ebert, Ph.D. Medha Ghosh, M.P.H. Julianne Reilly, B.S. Christina J. O&apos;Malley, M.H.A. Lauren Hahn, M.B.A. Nancy M. Mannion, D.N.P., R.N. Ann M. Huffenberger, D.B.A., R.N. Susan McGinley, C.R.N.P. Mohan Balachandran, M.A., M.S. Neda Khan, M.H.C.I. Judy A. Shea, Ph.D. Nandita Mitra, Ph.D. M. Kit Delgado, M.D. Perelman School of Medicine, University of Pennsylvania Philadelphia, PA amorga@pennmedicine.upenn.edu</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main" xml:id="_NcSrSBV">Morgan contributed equally to this letter. Supported by grants from the Patient-Centered Outcomes Research Institute (COVID-2020C2-10830</title>
		<author>
			<persName><surname>Drs</surname></persName>
		</author>
		<author>
			<persName><surname>Lee</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="m" xml:id="_DsvzdXb">the National Institutes of Health (K23HD090272001</title>
		<editor>
			<persName><forename type="first">Abramson</forename><surname>Family</surname></persName>
		</editor>
		<editor>
			<persName><forename type="first">Foundation</forename></persName>
		</editor>
		<imprint/>
	</monogr>
	<note>K08AG065444 Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org</note>
	<note type="raw_reference">Drs. Lee and Morgan contributed equally to this letter. Supported by grants from the Patient-Centered Outcomes Research Institute (COVID-2020C2-10830, to Dr. Delgado), the National Institutes of Health (K23HD090272001, to Dr. Del- gado, and K08AG065444, to Dr. Chaiyachati), and the Abramson Family Foundation (to Dr. Delgado). Disclosure forms provided by the authors are available with the full text of this letter at NEJM.org.</note>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main" xml:id="_jQhF3v2">Why COVID-19 silent hypoxemia is baffling to physicians</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Tobin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Laghi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Jubran</surname></persName>
		</author>
		<idno type="DOI">10.1164/rccm.202006-2157cp</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_cQGtyK6">Am J Respir Crit Care Med</title>
		<imprint>
			<biblScope unit="volume">202</biblScope>
			<biblScope unit="page" from="356" to="360" />
			<date type="published" when="2020">2020</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Tobin MJ, Laghi F, Jubran A. Why COVID-19 silent hypox- emia is baffling to physicians. Am J Respir Crit Care Med 2020; 202: 356-60.</note>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main" xml:id="_3Jmwemj">Remote management of covid-19 using home pulse oximetry and virtual ward support</title>
		<author>
			<persName><forename type="first">T</forename><surname>Greenhalgh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Knight</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Inda-Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">J</forename><surname>Fulop</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Leach</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Vindrola-Padros</surname></persName>
		</author>
		<idno type="DOI">10.1136/bmj.n677</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_dFEBAD5">BMJ</title>
		<imprint>
			<biblScope unit="volume">372</biblScope>
			<biblScope unit="page">677</biblScope>
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Greenhalgh T, Knight M, Inda-Kim M, Fulop NJ, Leach J, Vindrola-Padros C. Remote management of covid-19 using home pulse oximetry and virtual ward support. BMJ 2021; 372: n677.</note>
</biblStruct>

<biblStruct xml:id="b4">
	<monogr>
		<idno type="DOI">10.1332/policypress/9781447365884.003.0001</idno>
		<ptr target="https://www.england.nhs.uk/nhs-at-home/covid-oximetry-at-home/" />
		<title level="m" xml:id="_FgMARxN">COVID Oximetry @home</title>
		<imprint>
			<publisher>UK National Health Service</publisher>
		</imprint>
	</monogr>
	<note type="raw_reference">UK National Health Service. COVID Oximetry @home (https://www . england . nhs . uk/ nhs -at -home/ covid -oximetry -at -home/ ).</note>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main" xml:id="_TRwnXGG">Description and early results of the Kaiser Permanente Southern California COVID-19 Home Monitoring Program</title>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">N</forename><surname>Huynh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Millan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Quijada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>John</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Khan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Funahashi</surname></persName>
		</author>
		<idno type="DOI">10.7812/tpp/20.281</idno>
		<idno type="PMCID">PMC8784054</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_EbfBDTR">Perm J</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1" to="7" />
			<date type="published" when="2021">2021</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Huynh DN, Millan A, Quijada E, John D, Khan S, Funahashi T. Description and early results of the Kaiser Permanente South- ern California COVID-19 Home Monitoring Program. Perm J 2021; 25: 1-7.PMC8784054</note>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main" xml:id="_vC5yGXQ">Comparative effectiveness of an automated text messaging service for monitoring COVID-19 at home</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Delgado</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">U</forename><surname>Morgan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Asch</surname></persName>
		</author>
		<idno type="DOI">10.1056/NEJMc2201541</idno>
	</analytic>
	<monogr>
		<title level="j" xml:id="_KtSVNzR">Ann Intern Med</title>
		<imprint>
			<biblScope unit="volume">175</biblScope>
			<biblScope unit="page" from="179" to="190" />
			<date type="published" when="2022">2022</date>
		</imprint>
	</monogr>
	<note type="raw_reference">Delgado MK, Morgan AU, Asch DA, et al. Comparative ef- fectiveness of an automated text messaging service for monitor- ing COVID-19 at home. Ann Intern Med 2022; 175: 179-90. DOI: 10.1056/NEJMc2201541</note>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
